Andresen, Vibeke
Erikstein, Bjarte S
Mukherjee, Herschel
Sulen, André
Popa, Mihaela
Sørnes, Steinar
Reikvam, Håkon
Chan, Kok-Ping
Hovland, Randi
McCormack, Emmet
Bruserud, Øystein
Myers, Andrew G
Gjertsen, Bjørn T
Article History
Received: 2 May 2016
Revised: 4 October 2016
Accepted: 20 October 2016
First Online: 1 December 2016
Competing interests
: AGM holds a patent on the synthesis of avrainvillamide and analogs thereof (WO2006102097 A3). BTG and EMC owns shares in KinN Therapeutics AS. The remaining authors declare no conflict of interest.